A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation.

[1]  T. Martin,et al.  Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. , 2004, The Journal of clinical investigation.

[2]  T. Hirano,et al.  The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors , 2003, Cancer science.

[3]  Gideon A. Rodan,et al.  Control of osteoblast function and regulation of bone mass , 2003, Nature.

[4]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[5]  S. Takeda,et al.  Interleukin-11 as a Stimulatory Factor for Bone Formation Prevents Bone Loss with Advancing Age in Mice* , 2002, The Journal of Biological Chemistry.

[6]  T. Hirano,et al.  Molecular basis of the cell specificity of cytokine action. , 2002, Biochimica et biophysica acta.

[7]  Y. Saeki,et al.  A Point Mutation of Tyr-759 in Interleukin 6 Family Cytokine Receptor Subunit gp130 Causes Autoimmune Arthritis , 2002, The Journal of experimental medicine.

[8]  U. Lerner,et al.  IL-6, Leukemia Inhibitory Factor, and Oncostatin M Stimulate Bone Resorption and Regulate the Expression of Receptor Activator of NF-κB Ligand, Osteoprotegerin, and Receptor Activator of NF-κB in Mouse Calvariae1 , 2002, The Journal of Immunology.

[9]  G. Karsenty,et al.  Mouse α1(I)‐collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.

[10]  T. Hirano,et al.  Adapter Molecule Grb2-Associated Binder 1 Is Specifically Expressed in Marginal Zone B Cells and Negatively Regulates Thymus-Independent Antigen-2 Responses1 , 2002, The Journal of Immunology.

[11]  E. Wagner,et al.  Reaching a genetic and molecular understanding of skeletal development. , 2002, Developmental cell.

[12]  E. Wagner,et al.  Genetic control of skeletal development. , 2001, Current opinion in genetics & development.

[13]  K. Yasukawa,et al.  Signal through gp130 Activated by Soluble Interleukin (IL)‐6 Receptor (R) and IL‐6 or IL‐6R/IL‐6 Fusion Protein Enhances Ex Vivo Expansion of Human Peripheral Blood‐Derived Hematopoietic Progenitors , 2000, Stem cells.

[14]  T. Hirano,et al.  Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors , 2000, Oncogene.

[15]  T. Hirano,et al.  Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. , 2000, Immunity.

[16]  C. O’Brien,et al.  STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-κB Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone* , 1999, The Journal of Biological Chemistry.

[17]  S. Akira,et al.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.

[18]  T. Yoneda,et al.  Combination of Interleukin‐6 and Soluble Interleukin‐6 Receptors Induces Differentiation and Activation of JAK‐STAT and MAP Kinase Pathways in MG‐63 Human Osteoblastic Cells , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  A. Yamaguchi,et al.  Osteoclasts are present in gp130-deficient mice. , 1997, Endocrinology.

[20]  J. Darnell.  STATs and gene regulation. , 1997, Science.

[21]  J. Ihle.  STATs: Signal Transducers and Activators of Transcription , 1996, Cell.

[22]  F. Takahashi,et al.  Bone marrow neutrophilia and suppressed bone turnover in human interleukin-6 transgenic mice. A cellular relationship among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in bone marrow. , 1995, The American journal of pathology.

[23]  T. Martin,et al.  Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors , 1995, The Journal of experimental medicine.

[24]  S. Manolagas,et al.  Role of cytokines in bone resorption. , 1995, Bone.

[25]  H. Haugen,et al.  Developmental abnormalities in mice transgenic for bovine oncostatin M , 1995, Molecular and cellular biology.

[26]  J. Darnell,et al.  Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. , 1995, Annual review of biochemistry.

[27]  S. Akira,et al.  Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway , 1994, Cell.

[28]  G. Ciliberto,et al.  Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. , 1994, The EMBO journal.

[29]  I. Reid,et al.  The effect of leukemia inhibitory factor on bone in vivo. , 1993, Endocrinology.

[30]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.